Author:
Loveland Jerome,Abdelkader Hesham M.,El-Asmar Al Khaled M.
Publisher
Springer International Publishing
Reference46 articles.
1. Abu-Elmagd K, Bond G, Mazariegos G, et al. A new tolergenic immunosuppressive strategy for human intestinal transplantation. Transplantation. 2004;78:58.
2. Andersen D, DeVoll-Zabrocki A, Brown C, et al. Intestinal transplantation in pediatric patients: a nursing challenge, part two: intestinal transplantation and the immediate postoperative period. Soc Gastroenterol Nurses Assoc. 2000;23(5):201–9.
3. Barshes NR, Lee TC, Udell IW, O’Mahoney CA, Karpen SJ, Carter BA, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl. 2006;12:475–80.
4. Beath SV, Goyet JV, Kelly DA, et al. Current opinion in organ risk factors for death and graft loss after small bowel transplantation. Transplantation. 2003;8:195–201.
5. Benedetti E, Testa G. Living donor intestinal transplantation in pediatric recipients. Curr Opin Organ Transplant. 2006;11:543–5.